N-acetylcysteine and exacerbations of chronic obstructive pulmonary disease (Q36760096)

16 August 2017

0 references

1 reference

title

N-acetylcysteine and exacerbations of chronic obstructive pulmonary disease (English)

1 reference

chronic obstructive pulmonary disease

16 August 2017

main subject

1 reference

1 reference

E Rand Sutherland

1 reference

16 August 2017

James D Crapo

series ordinal

1 reference

16 August 2017

Russell P Bowler

series ordinal

1 reference

16 August 2017

language of work or name

English

0 references

publication date

1 December 2006

1 reference

COPD: Journal of Chronic Obstructive Pulmonary Disease

16 August 2017

published in

1 reference

16 August 2017

1 reference

16 August 2017

1 reference

16 August 2017

page(s)

195-202

1 reference

Standards for the diagnosis and treatment of patients with COPD: a summary of the ATS/ERS position paper

16 August 2017

cites work

1 reference

https://api.crossref.org/works/10.1080%2F15412550600977361

Smoking and lung function of Lung Health Study participants after 11 years

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F15412550600977361

Relationship between exacerbation frequency and lung function decline in chronic obstructive pulmonary disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F15412550600977361

Management of chronic obstructive pulmonary disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F15412550600977361

Inhaled corticosteroids reduce the progression of airflow limitation in chronic obstructive pulmonary disease: a meta-analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F15412550600977361

Oxidants in cigarette smoke. Radicals, hydrogen peroxide, peroxynitrate, and peroxynitrite

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F15412550600977361

Chronic obstructive pulmonary disease is associated with an increase in urinary levels of isoprostane F2alpha-III, an index of oxidant stress

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F15412550600977361

Effects of N-acetylcysteine on outcomes in chronic obstructive pulmonary disease (Bronchitis Randomized on NAC Cost-Utility Study, BRONCUS): a randomised placebo-controlled trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F15412550600977361

Improving the quality of reports of meta-analyses of randomised controlled trials: the QUOROM statement. Quality of Reporting of Meta-analyses

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F15412550600977361

21 January 2018

Meta-Analysis in Stata™

1 reference

https://api.crossref.org/works/10.1080%2F15412550600977361

Operating characteristics of a rank correlation test for publication bias

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F15412550600977361

A controlled trial of intermittent oral acetylcysteine in the long-term treatment of chronic bronchitis

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F15412550600977361

Orally administered N-acetylcysteine may improve general well-being in patients with mild chronic bronchitis

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F15412550600977361

N-acetylcysteine reduces the exacerbation rate in patients with moderate to severe COPD.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F15412550600977361

Superoxide dismutases in the lung and human lung diseases

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F15412550600977361

The cellular stress response induced by aqueous extracts of cigarette smoke is critically dependent on the intracellular glutathione concentration

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F15412550600977361

Efficacy of oral long-term N-acetylcysteine in chronic bronchopulmonary disease: a meta-analysis of published double-blind, placebo-controlled clinical trials

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F15412550600977361

The effect of oral N-acetylcysteine in chronic bronchitis: a quantitative systematic review

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F15412550600977361

Randomised, double blind, placebo controlled study of fluticasone propionate in patients with moderate to severe chronic obstructive pulmonary disease: the ISOLDE trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F15412550600977361

Still looking for answers in COPD.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F15412550600977361

The effects of inhaled corticosteroids in chronic obstructive pulmonary disease: a systematic review of randomized placebo-controlled trials

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F15412550600977361

Systemic oxidative stress in asthma, COPD, and smokers

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F15412550600977361

10.1080/15412550600977361

21 January 2018

Identifiers

DOI

1 reference

16 August 2017

1 reference